ATC Group: C07AA02 Oxprenolol

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C07AA02 in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C07 Beta blocking agents
3 C07A Beta blocking agents
4 C07AA Beta blocking agents, non-selective
5 C07AA02 Oxprenolol

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 0.16 g
PAREN - Parenteral 0.16 g

Active ingredients in C07AA02

Active Ingredient Description
Oxprenolol

Oxprenolol is a non-selective, lipophilic betablocker exerting a sympatholytic effect and displaying mild to modest partial agonistic activity (PAA), also known as intrinsic sympathomimetic activity (ISA). Oxprenolol decreases cardiac impulse formation in the sinus node with resultant slowing of the sinus rate.

Related product monographs

Title Information Source Document Type  
TRASICOR Film-coated tablets Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

Australia (AU)

Hong Kong (HK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.